Publication | Closed Access
Low‐dose rituximab in adult patients with primary immune thrombocytopenia
124
Citations
16
References
2010
Year
Low-dose rituximab is active in ITP but has moderate long-term effect. A comparative study with standard dose is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1